Microsoft (MSFT Quick QuoteMSFT - Free Report) and Apple (AAPL Quick QuoteAAPL - Free Report) , the US’s largest publicly traded companies, making up 10% of the S&P 500, reported powerful quarterly results this week. These trillion dollar companies are undoubtedly market moving stocks, yet the markets have traded down roughly 2.5% off its highs last week.

Investors may be beginning to pull profits off the table with the coronavirus seeming to be a good enough catalyst.

The S&P 500 is trading right off its highest forward P/E valuation since the dotcom bubble. The 2019 equity market was primarily driven by a valuation push as investors priced in future growth. If forward guidance doesn’t match expectations, there could be a pullback in the equities, especially those that have seen significant valuation multiple growth.

In this video I will discuss whether AAPL and MSFT have stretched their valuation multiples too far or if these stocks have more growth to be priced in.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>